Segmentation by type differentiates Sulphur Pastilles according to formulation and functional additives, clarifying how product design impacts market size. Natural sulfur pastilles, derived from elemental sulfur with minimal processing, appeal to health‑conscious consumers and represent roughly 35 % of the market, leveraging premium pricing. Synthetic sulfur pastilles, produced via controlled chemical synthesis, dominate the bulk segment (about 40 %) due to lower cost and consistent potency, satisfying high‑volume pharmaceutical distributors. Flavored sulfur pastilles, incorporating mint, citrus, or herbal essences, address palatability barriers and capture an estimated 15 % of sales, especially in regions where taste acceptance is critical. Sugar‑free sulfur pastilles, formulated with alternative sweeteners for diabetic or low‑calorie markets, hold a modest 10 % share but exhibit the highest growth rate, driven by expanding dietary‑restriction demographics. These type‑specific shares collectively define the market taxonomy and guide manufacturers’ R&D investments and portfolio diversification.